Home World News Similar Efficacy Between Subcutaneous and Intravenous Pembrolizumab Given with Chemotherapy for Treatment... World News Similar Efficacy Between Subcutaneous and Intravenous Pembrolizumab Given with Chemotherapy for Treatment of Patients with Metastatic NSCLC By Ogkologos - April 14, 2025 581 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the 3475A-D77 study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Datopotamab Deruxtecan Improves Survival Over Chemotherapy in Patients with Previously Untreated,... April 28, 2026 Judge Rules That 3-Year-Old Child With Leukemia Must Get Chemo Against... May 16, 2019 No improvement in OS, but more grade 3 or higher AEs... September 24, 2026 Short-Term Radiotherapy with Preoperative Chemotherapy Followed by Surgery is Efficacious with... March 21, 2022 Load more HOT NEWS Drug Regimen Boosts Survival of People with Advanced Colorectal Cancer ¿Los sobrevivientes del cáncer necesitan ser positivos todo el tiempo? Permitirse... Simple Hysterectomy Noninferior to Radical Hysterectomy with Respect to Pelvic Recurrence... Leveraging Extensive Real-World Data to Systematically Identify Mutations that Predict the...
